Examples of 'degarelix' in a sentence
Meaning of "degarelix"
Degarelix is a noun referring to a medication used to treat advanced prostate cancer
Show more definitions
- A hormonal therapy used in the treatment of prostate cancer.
How to use "degarelix" in a sentence
Basic
Advanced
degarelix
Degarelix is a synthetic decapeptide antagonist of GnRH.
It contains the active substance degarelix.
In each case degarelix was discontinued.
Cases of rhabdomyolysis have cumulativly been reported with degarelix.
Degarelix is the active ingredient of a drug for administration to humans.
Treatment of metastatic stage prostate cancer with degarelix.
Degarelix is a type of gnrh antagonist.
The active substance is degarelix.
Degarelix is a synthetic hormone blocker used in the treatment of prostate cancer.
Bone density has not been measured during treatment with degarelix.
Degarelix and alcohol.
Method of treating prostate cancer with the GnRH antagonist degarelix.
Degarelix is then released from the depot by diffusion in a sustained manner.
Animal reproduction studies showed that degarelix caused infertility in male animals.
Degarelix is injected under the skin at the abdominal region only.
See also
A preferred method for releasing degarelix from the support is by acid treatment.
Degarelix is a GnRH antagonist for use in the treatment of prostate cancer.
There is no clinical experience with the effects of an acute overdose with degarelix.
The effect of degarelix on insulin and glucose levels has not been studied.
Nine cases of inappropriate schedule of drug administration were reported cumulatively with degarelix.
Degarelix has been investigated in a pharmacokinetic study in patients with mild to moderate hepatic impairment.
There have been no immediate anaphylactic reactions reported in the degarelix clinical program.
In female reproduction toxicity studies degarelix revealed findings expected from the pharmacological properties.
There were no immediate anaphylactic reactions reported in this particular degarelix clinical program.
Degarelix is studied for use as a chemical castration agent on sex offenders in Sweden.
From baseline to end of study the median change in QTcF for degarelix was.
The injected liquid forms a gel from which degarelix is released over a period of one month.
It is also preferred for the peptide protected by Fmoc to be a fragment of degarelix.
Process for the manufacture of Degarelix and its intermediates.
In general, this invention relates to a liquid-phase synthesis of the decapeptide Degarelix.
In certain embodiments, the maintenance dose of degarelix is administered monthly.
Brief Description of the Figures Figure 1 is a depiction of the chemical structure of degarelix.
Drug-related local irritation was noted in animals when degarelix was administered subcutaneously in high doses.
After reconstitution, each ml of solution contains 20 mg of degarelix.
The further maintenance dose comprises degarelix or pharmaceutically acceptable salt thereof, an excipient, and a solvent.
FIRMAGON contains degarelix.
The structure of Degarelix can also be represented as,.
No testosterone microsurges were observed after re-injection during degarelix treatment.
If you are allergic ( hypersensitive ) to degarelix or any of the other ingredients of FIRMAGON.
After reconstitution 1 ml of the reconstituted solution contains 20 mg degarelix.
Each vial contains 80 mg degarelix as acetate.
Degarelix mimics a natural hormone ( gonadotrophin-relasing hormone, GnRH ) and directly blocks its effects.
The lowest effective maintenance dose of 80 mg degarelix was chosen.
The active substance is degarelix, each vial contains 80 mg degarelix.
Ml of the reconstituted solution contains 20 mg degarelix.
Degarelix pharmacokinetic parameters after subcutaneous administration of 240 mg at a concentration of 40 mg / mL Pharmacokinetic parameter.
The powder may be provided as a lyophilisate containing degarelix ( e.g. as acetate ) and mannitol.
Degarelix has an immediate onset of action and suppresses gonadotropins, testosterone, and prostate-specific antigen ( PSA ).
FIRMAGON 80 mg powder and solvent for solution for injection degarelix.
In vitro studies have shown that degarelix is not a substrate for the human CYP450 system.
